Loading...
Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
BACKGROUND: We assessed the utility of the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) as single agent therapy and in combination with conventional chemotherapy for thyroid cancer. METHODOLOGY/PRINCIPAL FINDINGS: Eight cell lines from four types of thyroid cancer (papillary, follicular, anaplastic,...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Public Library of Science
2012
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3471922/ https://ncbi.nlm.nih.gov/pubmed/23077520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0046726 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|